Latest Period
Q1 2026
Security Snapshot
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) Institutional Ownership
CUSIP: 45258J102
13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026
Institutions Reporting
214
Shares (Excl. Options)
110,594,133
Price
$24.84
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- IMVT on Nasdaq
- Shares outstanding
- 202,731,676
- Reported price per share
- $27.15
- Price from insider filings
- $27.15
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 110,594,133
- Total reported value
- $2,746,897,198
- Portfolio coverage rank
- 0.01%
- Share change
- +1,772,821
- Value change
- +$42,457,381
- Number of holders
- 214
Security identity
2 facts
Issuer context
3 facts
Latest holder snapshot
7 facts
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 45258J102.
- 214 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 194 to 214 between Q4 2025 and Q1 2026.
- Reported value moved from $2,761,164,222 to $2,746,897,198.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 214 institutions filings for Q1 2026.
Security key
45258J102
Latest holder period
Q1 2026
13F holders
214
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
IMVT full holder history
Immunovant, Inc. SEC filings
Immunovant, Inc. company facts
Immunovant, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45258J102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
IMVT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 56% | -1.8% | $2,812,776,314 | +$413,666,650 | 113,327,007 | +17% | Roivant Sciences Ltd. | 12 Dec 2025 |
| FMR LLC | 8.4% | -17% | $237,440,423 | -$37,858,433 | 14,729,555 | -14% | FMR LLC | 30 Sep 2025 |
| Deep Track Capital, LP | 5.6% | $144,590,000 | 9,500,000 | Deep Track Capital, LP | 19 Mar 2025 |
As of 31 Mar 2026, 214 institutional investors reported holding 110,594,133 shares of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT). This represents 55% of the company’s total 202,731,676 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
47%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 8.4% | 16,947,888 | -0.25% | 0.02% | $420,985,547 |
| Deep Track Capital, LP | 5.7% | 11,526,971 | 0% | 5.9% | $286,329,960 |
| BlackRock, Inc. | 3.2% | 6,574,497 | +8.5% | 0% | $163,310,512 |
| BAKER BROS. ADVISORS LP | 2.7% | 5,457,881 | 0% | 0.78% | $135,573,764 |
| STATE STREET CORP | 2.2% | 4,537,929 | +20% | 0% | $112,722,156 |
| TCG Crossover Management, LLC | 2.2% | 4,457,988 | +168% | 3.2% | $110,736,422 |
| MORGAN STANLEY | 1.9% | 3,876,877 | -20% | 0.01% | $96,301,649 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8% | 3,704,905 | 0% | 0% | $92,029,840 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8% | 3,620,050 | 0% | 0% | $89,922,042 |
| T. Rowe Price Investment Management, Inc. | 1.8% | 3,612,860 | -29% | 0.06% | $89,744,000 |
| ARMISTICE CAPITAL, LLC | 1.8% | 3,564,916 | -38% | 2.9% | $88,552,513 |
| Two Seas Capital LP | 1.6% | 3,201,962 | +12% | 3.7% | $79,536,736 |
| JENNISON ASSOCIATES LLC | 1.6% | 3,196,705 | +356% | 0.05% | $79,406,150 |
| RTW INVESTMENTS, LP | 1.6% | 3,177,849 | -0% | 0.79% | $78,937,769 |
| ADAR1 Capital Management, LLC | 1.3% | 2,679,010 | +8% | 4% | $66,546,608 |
| Alpine Global Management, LLC | 1.3% | 2,636,925 | +0.39% | 11% | $65,501,217 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 2,092,102 | +13% | 0% | $51,977,423 |
| Woodline Partners LP | 0.97% | 1,975,869 | 0% | 0.19% | $49,080,586 |
| GOLDMAN SACHS GROUP INC | 0.88% | 1,785,107 | +38% | 0.01% | $44,342,057 |
| PERCEPTIVE ADVISORS LLC | 0.79% | 1,597,383 | -20% | 0.78% | $39,678,994 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.76% | 1,546,000 | +12783% | 0.25% | $38,402,640 |
| Aberdeen Group plc | 0.57% | 1,160,762 | -2% | 0.05% | $28,833,328 |
| Logos Global Management LP | 0.53% | 1,075,000 | -22% | 1.4% | $26,703,000 |
| BANK OF AMERICA CORP /DE/ | 0.44% | 893,678 | +185% | 0% | $22,198,961 |
| STEMPOINT CAPITAL LP | 0.37% | 746,494 | +16% | 3.6% | $18,542,911 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
26
Latest
Q1 2026
Rows shown
1-25 of 26
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 110,594,133 | $2,746,897,198 | +$42,457,381 | $24.84 | 214 |
| 2025 Q4 | 108,607,774 | $2,761,164,222 | +$365,946,432 | $25.42 | 194 |
| 2025 Q3 | 95,145,471 | $1,533,747,121 | -$22,890,328 | $16.12 | 183 |
| 2025 Q2 | 96,203,927 | $1,539,273,430 | +$25,954,256 | $16.00 | 167 |
| 2025 Q1 | 94,088,777 | $1,608,317,726 | +$221,642,111 | $17.09 | 191 |
| 2024 Q4 | 80,137,358 | $1,984,988,003 | -$10,994,227 | $24.77 | 186 |
| 2024 Q3 | 79,205,377 | $2,259,063,728 | +$130,270,111 | $28.51 | 182 |
| 2024 Q2 | 74,718,656 | $1,972,484,501 | +$94,283,095 | $26.40 | 195 |
| 2024 Q1 | 70,316,923 | $2,271,922,665 | +$28,234,974 | $32.31 | 208 |
| 2023 Q4 | 68,405,672 | $2,881,981,571 | +$25,897,847 | $42.13 | 227 |
| 2023 Q3 | 68,143,903 | $2,616,088,544 | +$461,829,770 | $38.39 | 179 |
| 2023 Q2 | 55,460,743 | $1,051,890,599 | -$33,129,073 | $18.97 | 145 |
| 2023 Q1 | 58,264,079 | $903,668,302 | +$20,897,901 | $15.51 | 140 |
| 2022 Q4 | 56,538,511 | $1,003,523,628 | +$261,143,310 | $17.75 | 132 |
| 2022 Q3 | 42,668,627 | $238,077,080 | +$13,851,662 | $5.58 | 107 |
| 2022 Q2 | 40,117,493 | $156,470,492 | +$2,266,222 | $3.90 | 87 |
| 2022 Q1 | 39,493,605 | $217,710,240 | -$1,326,202 | $5.51 | 108 |
| 2021 Q4 | 37,845,291 | $322,423,547 | -$6,093,696 | $8.52 | 118 |
| 2021 Q3 | 33,769,857 | $293,475,463 | -$50,043,046 | $8.69 | 115 |
| 2021 Q2 | 38,555,821 | $407,535,405 | -$67,673,203 | $10.57 | 110 |
| 2021 Q1 | 40,251,421 | $645,603,475 | -$273,082,395 | $16.04 | 118 |
| 2020 Q4 | 40,331,237 | $1,862,979,798 | +$41,257,802 | $46.19 | 146 |
| 2020 Q3 | 39,828,501 | $1,401,617,459 | +$384,378,297 | $35.19 | 116 |
| 2020 Q2 | 28,564,750 | $695,567,285 | +$388,041,409 | $24.35 | 87 |
| 2020 Q1 | 12,628,676 | $193,544,419 | +$19,992,364 | $15.56 | 40 |